Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bumetanide analogue - NeuroPro Therapeutics

Next Previous
Drug Profile

Bumetanide analogue - NeuroPro Therapeutics

Alternative Names: NPT-2042

Latest Information Update: 07 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Neuropro Therapeutics
  • Class Antidementias; Antiepileptic drugs; Small molecules
  • Mechanism of Action Sodium-potassium-chloride symporter inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Absence epilepsy; Epilepsy

Most Recent Events

  • 11 Mar 2025 Phase-II clinical trials in Absence epilepsy (In adolescents, In adults, In the elderly, Treatment-experienced) in USA (PO) (NCT06769659)
  • 11 Mar 2025 Phase-II clinical trials in Epilepsy (In adults, In adolescents, In the elderly, Treatment-experienced) in USA (PO) (NCT06769659)
  • 10 Jan 2025 NeuroPro Therapeutics plans a phase II trial for Absence epilepsy and Epilepsy (In adolescents, In adults, In the elderly, Treatment-experienced) in USA (PO) in January 2025 (NCT06769659)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top